Centre for Amyloidosis and Acute Phase Proteins


Quality Assurance

As part of its commitment to quality, the National Amyloidosis laboratory participates annually in the external quality assurance schemes for Systemic Autoinflammatory Diseases, DNA sequencing NGS run by the European Molecular Genetics Quality Network (EMQN).  Copies of the results of these external quality assessments are available on request.  Currently, there is no equivalent scheme for hereditary amyloidosis.

Please help us improve the service and direct compliments and complaints in writing to the Quality Manager, Ania Baginska.

See the National Amyloidosis Centre Overview for more in-depth information on our services and The Registry of Hereditary Auto-inflammatory Disorders Mutations for information on hereditary fever genetics or The Registry for Mutations and Phenotypes in Hereditary Amyloidosis for information on hereditary amyloidosis genes.